Showing results (221-230 of 750) with videos related to

Sort By:
Pageof 75
Advances in Oto-Rhino-Laryngology|April 27, 2016
Cochlear Implantation in Children with Cochlear MalformationEtsuko Saikawa, Kenichi Takano, Noriko Ogasawara, et al.
The Journal of Antibiotics|August 1, 1986
Enhancement of 5-fluorouracil uptake into the bacterial cell by piperacillinM Takahata, Y Yamashiro, A Yotsuji, et al.
Heart (British Cardiac Society)|July 11, 1998
Circadian rhythm of the signal averaged electrocardiogram and its relation to heart rate variability in healthy subjectsM Nakagawa, T Iwao, S Ishida, et al.
Pacing and Clinical Electrophysiology : PACE|June 21, 2006
Influence of menstrual cycle on QT interval dynamicsMikiko Nakagawa, Tatsuhiko Ooie, Naohiko Takahashi, et al.
Ear, Nose, & Throat Journal|January 23, 2023
A Rare Case of Scalp Metastasis from Encapsulated Angioinvasive Follicular Thyroid CarcinomaMasataka Kojima, Shin Ito, Mako Saikawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
A novel single-nucleotide polymorphism in the 3'-untranslated region of the human dihydrofolate reductase gene with enhanced expressionY Goto, L Yue, A Yokoi, et al.
The Japanese Journal of Antibiotics|April 1, 1986
[Studies on absorption, distribution and excretion of 14C labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (14C-T-2588) in rats and mice]I Saikawa, T Maeda, Y Nakashima, et al.
International Journal of Clinical Oncology|August 19, 2007
Retrospective analysis of prognosis for scirrhous-type gastric cancer: one institution's experienceRieko Nakamura, Yoshiro Saikawa, Norihito Wada, et al.
Head & Neck|August 20, 2011
Narrow band imaging endoscopy for unknown primary tumor sites of the neckTakeshi Shinozaki, Ryuichi Hayashi, Mitsuru Ebihara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 1, 1993
[The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)]Y Suzuki, Y Miwa, H Akino, et al.
Pageof 75